Invivyd (IVVD.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec18

Invivyd Inc. Selects VBY329 as RSV Monoclonal Antibody Candidate

08:28

Nov24

Invivyd Inc.'s RSV Antibody Candidate VBY329 Shows Promising Preclinical Results

12:01

Nov18

Invivyd Inc Announces Public Offering of 44 Million Ordinary Shares at $2.50 Per Share and Pre-Funded Warrants

03:41

Nov6

Invivyd released FY2025 Q3 earnings on November 6 Pre-Market (EST), actual revenue USD 13.13 M (forecast USD 13.1 M), actual EPS USD -0.0615 (forecast USD -0.08)

14:30

Invivyd released FY2025 9 Months Earnings on November 6 Pre-Market EST, actual revenue USD 36.22 M, actual EPS USD -0.3195

14:30

Oct30

Invivyd to Release FY2025 Q3 Earnings on November 6 Pre-Market EST, Forecast Revenue USD 13.1 M, EPS USD -0.09

00:05

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 13.13 M, Net Income -10.47 M, EPS -0.0615

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 11.79 M, Net Income -14.66 M, EPS -0.1221

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 11.3 M, Net Income -16.29 M, EPS -0.1358

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change